MyAverix Finance
TO · Healthcare
Medipharm Labs Corp (LABS)
Drug Manufacturers - Specialty & Generic
Medipharm Labs Corp (LABS) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LABS
Medipharm Labs Corp (LABS) — FAQ
What is LABS's P/E ratio?
The price-to-earnings (P/E) ratio for Medipharm Labs Corp (LABS) is 18.00 (data as of 2026-05-24).
Does Medipharm Labs Corp pay a dividend?
Dividend yield is not available in the current snapshot for Medipharm Labs Corp (LABS). Check the MyAverix Finance app for the latest dividend data.
What sector is Medipharm Labs Corp in?
Medipharm Labs Corp (LABS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LABS listed on?
LABS is listed on TO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.